ArticleAntimicrobial agents and chemotherapy2014

Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.

Rafael F Duarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.